Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan® Dx Assay. This assay is intended for the postnatal detection of DNA copy ...
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Takeda Pharmaceutical's new drug application (NDA) of Adcetris (brentuximab vedotin) 50mg intended to treat patients with CD30 positive relapsed or refractory hodgkin ...
Naturally Splendid Enterprises is pleased to announce an agreement with Purity Life Health Products LP "Purity Life" to distribute its NATERA superfood line across Canada. Purity Life was founded in 1984 and is Canada's leading ...
Medtronic, a medical device company, has obtained the US Food and Drug Administration (FDA) approval for its CoreValve self-expanding transcatheter system. The device is designed for severe aortic stenosis patients who are too ill or ...
Tags: medical device, Medtronic
Affymetrix, a manufacturer of DNA microarrays, has obtained marketing authorization from the US Food and Drug Administration (FDA) for its Affymetrix CytoScan Dx assay that can detect chromosomal variations which may be responsible for a ...
Tags: FDA Approval, Cytoscan DX Assay
As co-ordinator of the European project 'ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the ...
Tags: Construction, Decoration, Ceram-Lead Project
Going barefoot in parts of Africa, Asia and South America contributes to hookworm infections, which afflict an estimated 700 million of the world's poor. The parasitic worm lives in the soil and enters the body through the feet. By feeding ...
Researchers say they've discovered how the club drug Ecstasy acts on the brain, and their findings suggest the drug might be useful in treating anxiety and post-traumatic stress disorder. The study included 25 volunteers who underwent two ...
Bayer HealthCare has failed to win the backing of the US FDA's Cardiovascular and Renal Drugs Advisory Committee to expand the use of its oral anticoagulant Xarelto (rivaroxaban) 2.5 mg twice daily (BID) in combination with standard ...
Tags: FDA Panel, ACS Patients
Sen. Sherrod Brown of Ohio, like many politicians in Washington, hastily reacted to a media report in his home state before researching and understanding the background and facts about safety regulations and precautions in the truck ...
Every week reporter Ankita Rao selects interesting reading from around the Web. NPR: 5 Simple Habits Can Help Doctors Connect With Patients I'd never [before] been encouraged to sit at a patient's bedside -; to stop hurrying for even a ...
Tags: Obesity Origins, Children with Chronic Disease, Health&Medicine
Free speech is perhaps our most cherished civil liberty. Without free speech -; especially free speech on key cultural, political and religious issues -; the United States is no longer the pluralistic republic envisioned by our Founders. ...
Tags: Health Care, Debate Health Care, Young People Signed up for Health Care
Brain imaging experiments have revealed for the first time how ecstasy produces feelings of euphoria in users. Results of the study at Imperial College London, parts of which were televised in Drugs Live on Channel 4 in 2012, have now ...
Tags: Clinical Uses of Ecstasy
A new class of molecules called acyldepsipeptides-ADEPs-may provide a new way to attack bacteria that have developed resistance to antibiotics. Researchers at Brown and MIT have discovered a way to increase the potency of ADEPs by up to ...
The U.S. Food and Drug Administration approved on Friday a first-of-its-kind blood test that can scan a child's genetic code and spot possible genetic explanations for developmental delays or intellectual disabilities. The test can ...